1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Key Pharma News 17 NOVEMBER 2014

Key Pharma News 17 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 29 pages

Industry Trend Analysis - Conference Reveals Future Diversification Of HCV Market
Industry Brief - Intarcia/Servier Sign Ex-US Partnership For ITCA 650 In Diabetes
Industry Brief - Genmab Transfers Ofatumumab Collaboration From GSK To Novartis
Industry Trend Analysis - Merck Places Confidence In Accurin Technology After Amgen's Exit
Industry Brief - BI/Lilly Revise Operational Structure Of Diabetes Alliance
Industry Brief - Pain Therapeutics To Regain Full Rights To Remoxy From Pfizer
Industry Trend Analysis - Oncology Will Be A Major Growth Driver For Amgen
Industry Trend Analysis - Sandoz Looks To Overturn Teva's Dominance
Industry Brief - Sanofi's Board Decides To Remove Viehbacher As CEO
Industry Trend Analysis - AstraZeneca Fast-Tracks Into Up-And-Coming LABA/LAMA Market
Industry Trend Analysis - BMS Interest Underlines Vitality Of Underserved IPF Market
Industry Trend Analysis - AstraZeneca Strengthens Immuno-Oncology Capabilities With Diagnostics Acquisition
Industry Brief - UCB To Sell Kremers To Private Equity Firms
Industry Trend Analysis - Dendreon Unlikely To Find Buyer With Provenge's Underperformance
Industry Trend Analysis - Ranbaxy Results Show Overall Strengthening As Sun Merger Approaches
Industry Brief - Eisai Neuroscience Business Officially Launched In Belgium And Luxembourg
Industry Trend Analysis - Branded Acquisitions Drive Actavis Forward, But Generics Remain Important
Industry Brief - FDA Accepts Boehringer's NDA For Additional Spiriva Respimat Indication
Industry Brief - FDA Approves Once-Daily Xigduo XR For Adults With Type II Diabetes
Industry Trend Analysis - Olysio's Additional FDA Approval Causes Little Change To Poor Sales Outlook
Industry Trend Analysis - FDA ODAC Vote Against MM Drug Is A Bad Start To Novartis' New Oncology Focus
Industry Trend Analysis - Avanir's Inhaled Migraine Therapy Will Not Be FDA-Approved In November
Industry Brief - GSK Files Regulatory Submissions For Mepolizumab In Severe Eosinophilic Asthma
Industry Trend Analysis - Eisai's Fycompa Will Remain Off German Market
Industry Brief - FDA Advisory Committee Recommends Edoxaban Approval In NVAF
Industry Brief - Gilead Seeks FDA Approval For TAF-Based Single-Tablet HIV Regimen
Industry Brief - FDA Approves Cyramza+Paclitaxel Combination for Advanced/Metastatic GC
Industry Brief - FDA Rescinds Ranbaxy Exclusivities Creating Opportunity For Dr Reddy's And Endo
Industry Trend Analysis - Jakavi's Myelofibrosis Monopoly Set To End
Industry Trend Analysis - Smoking Cessation: A Blockbuster Opportunity For Belviq
Industry Trend Analysis - Future Of Amgen's Trebananib In Question After Disappointing Overall Survival Results
Industry Brief - FDA Removes Full Clinical Hold On Imetelstat
Industry Trend Analysis - Brodalumab's Emerging Success In Plaque Psoriasis Heralds Competitive Edge

Table Of Contents

Key Pharma News 17 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...

Single-use Bioprocessing Market by Product, Application, End User - Global Forecast to 2021

Single-use Bioprocessing Market by Product, Application, End User - Global Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

Rising Biopharmaceutical Demand and Increasing Investments in R&D Activities Drive Growth of the Single-use Bioprocessing Market The global single-use bioprocessing market is projected to reach USD 5.44 ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.